NewAmsterdam Pharma (NAMS) Enterprise Value (2021 - 2026)
NewAmsterdam Pharma's Enterprise Value was $3.35 billion in Q2 2026, up 158.3% from $1.3 billion a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Enterprise Value (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, NewAmsterdam Pharma's Enterprise Value was $1.38 billion through Jun 30, 2026; for FY2025, it was $3.38 billion, up 73.8% from FY2024.
- Enterprise Value has now increased for four consecutive years, with a four-year compound annual growth rate of 109.5% (FY2021 to FY2025).
- In earlier years, Enterprise Value was $1.94 billion in FY2024 (+234.6%), $580.74 million in FY2023 (+37.9%), $421.27 million in FY2022 (+140.5%) and $175.15 million in FY2021.
- Quarterly Enterprise Value has moved between $144.7 million (Q2 2022) and $3.38 billion (Q4 2025) over five years.
- Compared with a year earlier, Enterprise Value has increased for four straight quarters, with growth averaging 109.2% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2023 (growth of 288.5%); the worst was Q1 2025 (a decline of 9.3%).
- Per Business Quant data, NAMS's Enterprise Value in the three quarters before Q2 2026 was $3.1 billion (Q1 2026), $3.38 billion (Q4 2025) and $2.52 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | NewAmsterdam Pharma | 2.43 Bn | -108.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.29 Bn |
| Jun 30, 2026 | 3.35 Bn |
| Mar 31, 2026 | 3.10 Bn |
| Dec 31, 2025 | 3.38 Bn |
| Sep 30, 2025 | 2.52 Bn |
| Jun 30, 2025 | 1.30 Bn |
| Mar 31, 2025 | 1.49 Bn |
| Dec 31, 2024 | 1.94 Bn |
| Sep 30, 2024 | 1.11 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 1.64 Bn |
| Dec 31, 2023 | 580.74 Mn |
| Sep 30, 2023 | 394.54 Mn |
| Jun 30, 2023 | 562.13 Mn |
| Mar 31, 2023 | 642.93 Mn |
| Dec 31, 2022 | 421.50 Mn |
| Dec 31, 2021 | 175.15 Mn |
API Access
NewAmsterdam Pharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();